Purpose: It is debated whether treatment delay worsens oncologic results in localized prostate cancer (PCa). Few studies have focused on the role of a delay between the time of biopsy and the time of surgery. Thus, we aimed to investigate the effect of the time period between biopsy and surgery on Gleason score upgrading (GSU). Materials and Methods: A total of 290 patients who underwent radical retropubic pros-tatectomy in Ankara Training and Research Hospital were included in the study. The biopsy Gleason score, age, total prostate-specific antigen (PSA) value, prostate vol-umes, and PSA density (PSAD) were analyzed in all patients. The patients were divided into two groups: patients with GSU (group 1) and patients without GSU (group 2). ...
OBJECTIVE: To test the prognostic role of treatment delay in patients affected by prostate cancer (...
Purpose: There have been only a few contradictory publications assessing whether Gleason score 4 + 3...
PURPOSE: To evaluate whether the rate of Gleason score (GS) upgrade on final pathology, the rate of ...
PURPOSE: Gleason score is one of the most important prognostic indicators for prostate cancer. Downg...
Context: Biopsy Gleason score (b-GS) is often different from the Gleason score obtained after analys...
Context: Biopsy Gleason score (b-GS) is often different from the Gleason score obtained after analys...
Purpose: To identify the prostate cancer detection rate on the patients who had second prostate biop...
Background: The introduction of prostate-specific antigen (PSA) testing has not only shor-tened the ...
Purpose: We evaluated oncologic outcomes following radical prostatectomy (RP) in pa-tients with a Gl...
Objective: We evaluated the preoperative parameters to predict a positive surgical margin (SM) at ra...
Purpose: The Gleason score (GS) is an important factor that is considered when making decisions abou...
Purpose: The aim of this study was to investigate clinicopathologic differences between prostate can...
OBJECTIVE: To test the prognostic role of treatment delay in patients affected by prostate cancer (...
Purpose: This study aimed to improve prostate biopsy compliance by analyzing the fac-tors that influ...
OBJECTIVE: To test the prognostic role of treatment delay in patients affected by prostate cancer (...
OBJECTIVE: To test the prognostic role of treatment delay in patients affected by prostate cancer (...
Purpose: There have been only a few contradictory publications assessing whether Gleason score 4 + 3...
PURPOSE: To evaluate whether the rate of Gleason score (GS) upgrade on final pathology, the rate of ...
PURPOSE: Gleason score is one of the most important prognostic indicators for prostate cancer. Downg...
Context: Biopsy Gleason score (b-GS) is often different from the Gleason score obtained after analys...
Context: Biopsy Gleason score (b-GS) is often different from the Gleason score obtained after analys...
Purpose: To identify the prostate cancer detection rate on the patients who had second prostate biop...
Background: The introduction of prostate-specific antigen (PSA) testing has not only shor-tened the ...
Purpose: We evaluated oncologic outcomes following radical prostatectomy (RP) in pa-tients with a Gl...
Objective: We evaluated the preoperative parameters to predict a positive surgical margin (SM) at ra...
Purpose: The Gleason score (GS) is an important factor that is considered when making decisions abou...
Purpose: The aim of this study was to investigate clinicopathologic differences between prostate can...
OBJECTIVE: To test the prognostic role of treatment delay in patients affected by prostate cancer (...
Purpose: This study aimed to improve prostate biopsy compliance by analyzing the fac-tors that influ...
OBJECTIVE: To test the prognostic role of treatment delay in patients affected by prostate cancer (...
OBJECTIVE: To test the prognostic role of treatment delay in patients affected by prostate cancer (...
Purpose: There have been only a few contradictory publications assessing whether Gleason score 4 + 3...
PURPOSE: To evaluate whether the rate of Gleason score (GS) upgrade on final pathology, the rate of ...